Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
Yutao Guo1*, Qiang Wu2*, Lu Zhang1, Tingshu Yang1, Ping Zhu1, Wenqian Gao1, Yuexiang Zhao1, Meng Gao11Department of Geriatric Cardiology, 2Department of Clinical Administration, General Hospital of The Chinese PLA, Beijing, China; *Shared equal authorshipAbstract: Although attention has been given t...
Guardado en:
Autores principales: | Yutao Guo, Qiang Wu, Lu Zhang, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8790235dd92e4815812236378d30dab4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Abdelmoniem Moustafa, et al.
Publicado: (2019) -
Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
por: Xiang W, et al.
Publicado: (2015) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo P, et al.
Publicado: (2011) -
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
por: Abdelmoniem Moustafa, et al.
Publicado: (2020) -
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
por: Guo Y, et al.
Publicado: (2011)